Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

9,337 stories indexed, page 123 of 156

🇮🇳CDMOpiramalpharmasolutions.com

Integrated Operations in Early-Stage Development

Piramal Pharma SolutionsOriginal source
🇮🇳CDMOpiramalpharmasolutions.com

HPAPI Containment & Safe Pharmaceutical Manufacturing

Piramal Pharma SolutionsOriginal source
🇮🇳CDMOpiramalpharmasolutions.com

HPAPI Processing & Manufacturing Guide for Pharma

Piramal Pharma SolutionsOriginal source
🇮🇳CDMOpiramalpharmasolutions.com

Ozonolysis for API Manufacturing | Efficient Oxidation

Piramal Pharma SolutionsOriginal source
🇮🇳CDMOpiramalpharmasolutions.com

Process Innovation for Cost-Effective Cyclic Peptide Synthesis

Piramal Pharma SolutionsOriginal source
🇮🇳CDMOpiramalpharmasolutions.com

Chromatography in Pharma for Drug Purification

Piramal Pharma SolutionsOriginal source
🇮🇳CDMOpiramalpharmasolutions.com

Biocatalysis for Scalable API Synthesis | PPS

Piramal Pharma SolutionsOriginal source
🇮🇳CDMOpiramalpharmasolutions.com

Leachable Impurity Assessment & ICH Q3E Guide

Piramal Pharma SolutionsOriginal source
🇮🇳CDMOpiramalpharmasolutions.com

Antibody Drug Conjugates in Precision Oncology

Piramal Pharma SolutionsOriginal source
🇮🇳CDMOpiramalpharmasolutions.com

Analytical Method Validation: Principles & Best Practices

Piramal Pharma SolutionsOriginal source
🇮🇳CDMOpiramalpharmasolutions.com

Piramal Pharma Solutions - Latest Press Releases

Piramal Pharma SolutionsOriginal source
🇮🇳CDMOpiindustries.com

Press Releases - PI Industries

PI Industries (Pharma)Original source
🇯🇵Industryphchd.com

PHC Launches Cell-IQ ® CO 2 Incubators with Active Humidity Control, Creating Critical Stability for Research Samples Jun.18, 2026 PHC

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Stakeholder Engagement | Sustainability | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Sustainability Management | sustainability | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Integrated Report | sustainability | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Patient Record & Billing Solutions | Products & Services | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Medical Device & Drug Delivery | Products & Services | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Diagnostic Testing | Products & Services | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Diabetes Management Technology | Products & Services | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Precision Anatomical Pathology for Cancer | Products & Services | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Cell Growth & Preservation | Products & Services | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Announcement of Corporate Officers at PHC Holdings Corporation Effective June 24, 2026 | 2026 | News | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Epredia Launches SlideMate™ Thermal Slide Printer, Delivering On-Demand Slide Printing and Enhanced Traceability for Pathology Laboratories May.14, 2026 Epredia

PHC CorporationOriginal source
🇯🇵Industryphchd.com

2026 | News | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

2025 | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

2024 | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

General Meeting of Shareholders | IR | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Historical Financial Data | IR | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Analyst Coverage | IR | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Search Result | PHC Holdings Corporation

PHC CorporationOriginal source
🇯🇵Industryphchd.com

Ascensia | PHC Corporation

PHC CorporationOriginal source
🇫🇷Researchpasteur.fr

The universal tempo of animal communication

Institut PasteurOriginal source
🇫🇷Researchpasteur.fr

Institut Pasteur Korea and the Institut Pasteur Open a New Chapter in Strategic Collaboration

Institut PasteurOriginal source
🇫🇷Researchpasteur.fr

Accelerating Chikungunya Vaccine Development in Africa: Launch of the ACT-CHIK Project

Institut PasteurOriginal source
🇬🇧Investorovg.ox.ac.uk

World's first Phase II Nipah virus vaccine trial launch

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

UK-China Workshop on Immunisation Policy Research hosted by Oxford Vaccine Group

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

The UK’s childhood vaccination schedule just changed. Here’s why that’s actually reassuring

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

The meningitis vaccine now sits at the centre of two health crises

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

Public scepticism of vaccination is rising- social scientists call for a rethink of research

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

Oxford Vaccine Group launches a first-in-human trial to test a vaccine against the Lassa virus

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

Oxford-led study shows vaccine protection against Salmonella Paratyphi A

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

Oxford launches major new AI vaccine research programme with the Ellison Institute of Technology

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

Major investment puts UK universities at the forefront of groundbreaking lymph node research

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

HRH The Duke of Gloucester Visits University of Oxford’s Cutting-Edge Vaccine Facilities

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

First Volunteer Receives Lassa Fever Vaccine in Cutting-edge Oxford Trial

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

Dr Young Chan Kim appointed Director of Graduate Studies

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

Bangladeshi children are now protected from typhoid

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

Ambitious research aims to develop multivalent vaccines to protect against multiple deadly filoviruses

Oxford Vaccine Group (Latest)Original source
🇬🇧Investorovg.ox.ac.uk

20 Years of Collaboration between OVG and Paediatric Research Unit, PAHS, Nepal

Oxford Vaccine Group (Latest)Original source
🇯🇵Industryono-pharma.com

勤務継続型譲渡制限付株式報酬および業績連動型譲渡制限付株式報酬としての自己株式の処分に関するお知らせ | ONO CORPORATE

Ono PharmaceuticalOriginal source
🇯🇵Industryono-pharma.com

オプジーボ®点滴静注、根治切除不能な甲状腺未分化がんに対する効能または効果の追加に係る国内製造販売承認事項一部変更承認申請 | ONO CORPORATE

Ono PharmaceuticalOriginal source
🇯🇵Industryono-pharma.com

ブリストル マイヤーズ スクイブ、欧州において、進行期古典的ホジキンリンパ腫のファーストライン治療として、オプジーボとAVDの併用療法の承認を取得したことを発表 | ONO CORPORATE

Ono PharmaceuticalOriginal source
🇯🇵Industryono-pharma.com

2026.06.02 研究開発 ONO-4578(EP4 拮抗薬)の胃がんを対象とした第 2 相臨床試験での新たなデータを2026 年米国臨床腫瘍学会(ASCO)年次総会において発表

Ono PharmaceuticalOriginal source
🇯🇵Industryono-pharma.com

2026.05.28 研究開発 ONO-2808(S1P5 受容体作動薬)の多系統萎縮症を対象とする第 2 相臨床試験の新たなデータを第 7 回世界パーキンソン病学会(WPC)において発表

Ono PharmaceuticalOriginal source
🇯🇵Industryono-pharma.com

2026 年米国臨床腫瘍学会(ASCO)年次総会においてがん領域の新たなデータを発表 | ONO CORPORATE

Ono PharmaceuticalOriginal source
🇯🇵Industryono-pharma.com

2026.03.26 研究開発 小野薬品、進行性の消化管間質腫瘍(GIST)に対する治療薬「ripretinib(DCC-2618)」の国内での承認申請

Ono PharmaceuticalOriginal source
🇯🇵Industryono-pharma.com

ブリストル マイヤーズ スクイブ、米国および欧州においてオプジーボの適応症を拡大し、古典的ホジキンリンパ腫の治療パラダイムを変革 | ONO CORPORATE

Ono PharmaceuticalOriginal source
🇯🇵Industryono-pharma.com

Vertex社がPovetaciceptのグローバル第Ⅲ相臨床試験であるRAINIER試験の中間解析結果を発表 | ONO CORPORATE

Ono PharmaceuticalOriginal source